# AstraZeneca Breast-Cancer Drug Misses Goal in Late-Stage Trial

> **Newsylist Open Intelligence Dossier** · First detected: 2026-09-14 09:29 UTC · Category: Business · Sources: 7 · Current Velocity: 4.63

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| reuters.com | AstraZeneca's breast cancer pill fails in late-stage trial | 2026-09-14 06:02 | [Source Link](https://news.google.com/rss/articles/CBMixAFBVV95cUxOM2NSc05zS3hrYWUweWU3amhMMVk2U2x0eEx4Ny1pMWVZbkhmS1NVSkVBWU9JMDY1SjNDNTg2N1pMeElKancxNmI5TGFGaU5ORU1qbnNvakt2ZUdiczNhclpUaTJBYklfMmJqaXZHUXQ0TlRhcXRwTnJYeVUtR3ZMM0c0NC1xZTl3N2xFSTBpVFVqOUIySmRzaVV6UWVZeTJveFhiUzhERGs2UEtUTl9Db085eTltX3BtMG9EMXlvdkhyeE93?oc=5) |
| FirstWord Pharma | AstraZeneca's oral SERD stumbles in Phase III first-line breast cancer trial | 2026-09-14 06:02 | [Source Link](https://news.google.com/rss/articles/CBMiU0FVX3lxTE5rMmNERmhBOUVGSnBEbGRxLVFLdVlsRGc2b1FHMndOY053YWlwOUI1dlo3YkZqVmdCU05DOHQ3dEZjbkoxSXZ2NDRneHFuMGt4anFV?oc=5) |
| Bloomberg.com | Astra Breast Cancer Pill Miss May Trim Billions From Sales | 2026-09-14 06:02 | [Source Link](https://news.google.com/rss/articles/CBMitgFBVV95cUxOYlZzZVpCcnFQQlhDMERXQU9uVlRfY3JZN0NGVnAtLWNTaE5IcTV3RVpBY2V0Y1VlOVM5Z2RCTzRHUlhuR0JRQ2V6ZUQtTmhNdEd2aVBXaXhJSUVwLWlrT0NfVmFsSzdfSEt5QjIzRUNQOEhjaXJUZGJKM25LbFhiS0RDa1RRWXRUSThMVHZDTU9QS1VpdUREenlHYjVJa2RuQWhlMlFjMUJ1akZtRXIxY0dxZm0zQQ?oc=5) |
| fiercepharma.com | AstraZeneca’s Etcamah flunks first-line breast cancer trial, adding to oral SERDs’ failure record | 2026-09-14 06:02 | [Source Link](https://news.google.com/rss/articles/CBMixAFBVV95cUxOeGRoQWZMLXdrZmQ2ZG5OMlJlWnh3RDJUc3BOc2VWVk8yd3l1MS05aFFvUkJQYkJNbTNxMUZvbDlfcUozMlZpV3N4aGhEaksyUXh1OHpoVkszTXlaeGs3aTAwWDAtZEJzX0twQkx3eUxGaElnMS1qLS1jUXo3YTlpTnR5Mll2RVN2T2diTlZQU1d3OHdBMHNueHdmbEg2d0dQUDQyRm9xeTVuM08yb2twWGloS0x0dWJSei1lTmhaOTNMdTho?oc=5) |
| STAT | Breast cancer pill from AstraZeneca misses mark in pivotal trial | 2026-09-14 06:02 | [Source Link](https://news.google.com/rss/articles/CBMiqgFBVV95cUxNakVrZWtCczdqMmM5UUVJdHloMVBndEVKaXdqT2pXZkhveUo4QmVUZWtrNXQzOVBueTM0QUMzbjRBLWQzT1hGRFU1VFQ1Q0lUWFVEdjZvTjgzckZ0RXJkN1YxNVVOeDNpVXhjUmgwNGFheEFXVms1b0ZiYjNETjlmbGdYek9USVhoRG1rWUZ0S1RUdFQyVXpaVVEzX3FadU45WXVrMEtJc1dlZw?oc=5) |
| AstraZeneca | Update on SERENA-4 Phase III trial of Etcamah in combination with palbociclib in upfront 1st-line advanced ER-positive breast cancer | 2026-09-14 06:02 | [Source Link](https://news.google.com/rss/articles/CBMingFBVV95cUxQOWhSaDhaTjlmSXpwNVZTRWg3ZWlRTmhzWmY1cjZuellfcHRsSVMyVkZESm5IY2RBSjdxNGJSNEpxYThwR0FvS1ppLXdJaXRKNTlwdC1CTlpWTU1oUjlLam9ZN1VNZXdXOUlXYzl3bFZsM0dvbDF2cHlwSjBXbUFjT0FVMkhnZ0s3OE9FamhJaEY2bl9fb1pxVDlYcnJkdw?oc=5) |
| WSJ | AstraZeneca Breast-Cancer Drug Misses Goal in Late-Stage Trial | 2026-09-14 06:02 | [Source Link](https://news.google.com/rss/articles/CBMiqAFBVV95cUxPTWtuUURLQ2x4Qld3alJZLUxaMjVNVGFkY29Ybk15TUJ6SDgwZ0JKalhQUXBjYU90dmpHN2tjVkhDWG5FMWY3UUcwa1UzMnFEQTBMQ2ozbURjTVRWSW1LTGZMUDBpanFSaFdIaG1NNHRFRXYtbjEwTVhnWVJKMGZwX3NvOHk3Mk1KN1FmblpRSFhhS3FFUHNnTy1JaXFjQ0hrcHJvLVRKUjQ?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-09-14/astrazeneca-breast-cancer-drug-misses-goal-in-late-stage-trial*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*